Mechanism of repetitive transcranial magnetic stimulation (rTMS) to improve inhibitory control in patients with insomnia disorder

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061186

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia disorders

Interventions

Insomniacs:Real transcranial magnetic stimulation

Insomniacs: Sham transcranial magnetic stimulation

Healthy control group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria for insomnia disorders: 1. age 18-65; 2. PSQI score > 6; 3. No neurological or mental illness; 4. No other sleep disorders (such as sleep-related dyskinesia, hypersomnia, or dyssomnia) were assessed clinically and polysomnographically. The healthy control group: 1. 18-65 years old. 2. No other sleep disorders; 3. Good sleep quality, no alternating day and night work history; 4. PSQI 5 or less; 5. No neurological or mental illness.

Exclusion criteria

Exclusion criteria: 1. Metal implants (such as pacemakers, stents, inner ear hearing AIDS, or other metal objects) in patients; 2. History of seizures; 3. Women who are pregnant or breast-feeding or menstruating or taking hormones; 4. Structural brain injury detected by BRAIN MRI scan; 5. No opioids, sedative-hypnotics, antipsychotics, antidepressants, B-blockers, stimulants, mood stabilizers, or thyroid/diabetes medications.

Design outcomes

Primary

Measure	Time frame
Electroencephalogram;Behavioral indicators;	—

Countries

China

Contacts

Public ContactXiaobin Ding

258488908@qq.com+86 15095390723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026